These myokines, such as osteoprotegerin (OPG), a member of the TNF receptor superfamily, are being evaluated therapeutically for replacement of pancreatic β-cells destroyed in T1D. This evidence concerns the gene TNFRSF11B and type 1 diabetes mellitus.